Valuation : CellaVision AB

Market Cap 3.84B 401M 344M 324M 296M 553M 38.12B 555M 1.48B 19.46B 1.5B 1.47B 61.98B P/E 2026 *
27.6x
P/E 2027 * 22x
Enterprise Value 3.65B 381M 327M 308M 281M 526M 36.26B 528M 1.41B 18.51B 1.43B 1.4B 58.95B EV / Sales 2026 *
4.71x
EV / Sales 2027 * 4.16x
Free-Float
81.06%
Yield 2026 *
1.71%
Yield 2027 * 1.95%
1 day-0.74%
1 week-2.19%
Current month-3.25%
1 month+5.64%
3 months+25.39%
6 months+5.50%
Current year+2.42%
1 week 157.6
Extreme 157.6
164.4
1 month 150.2
Extreme 150.2
170.4
Current year 117.6
Extreme 117.6
170.4
1 year 117.6
Extreme 117.6
192.2
3 years 117.6
Extreme 117.6
302
5 years 117.6
Extreme 117.6
462.6
10 years 70.75
Extreme 70.75
503.5
Manager TitleAgeSince
Chief Executive Officer - 2026-06-04
Director of Finance/CFO 46 2025-09-01
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member 61 -
Director/Board Member 62 2018-05-03
Chairman 64 2021-04-28
Date Insider Type Main position Quantity % Market Cap. Importance
9/2/26 Free 100,000 0.4193%
4/28/26 Don

Founder

76,434 0.3205%
4/28/26 Buy

Founder

20,000 0.0839%
Change 5-day change 1-year change 3-year change Capi.($)
-0.74%-2.19%-7.79%-10.85% 404M
-0.55%-4.21%+21.28%-32.15% 17.12B
-2.34%+6.87%-32.09%+54.17% 1.75B
-5.53%-8.07%-55.60%-83.07% 918M
-1.27%-4.67%-23.85%+20.80% 918M
+0.05%+0.16%+58.53%-3.09% 779M
-1.94%-3.55%-34.99%-47.28% 679M
-2.30%-1.25%-42.24%-44.83% 619M
+2.90%-21.50%-46.08%-42.43% 420M
-1.22%-9.01%+71.81%+51.17% 405M
Average -1.29%-4.12%-9.10%-13.76% 2.4B
Weighted average by Cap. -0.92%-3.18%+9.90%-24.01%

Financials

2026 *2027 *
Net sales 775M 80.92M 69.48M 65.44M 59.68M 112M 7.7B 112M 299M 3.93B 304M 297M 12.51B 870M 90.82M 77.99M 73.45M 66.99M 125M 8.64B 126M 336M 4.41B 341M 333M 14.04B
Net income 139M 14.51M 12.46M 11.74M 10.7M 20.02M 1.38B 20.1M 53.71M 704M 54.45M 53.28M 2.24B 174M 18.2M 15.63M 14.72M 13.43M 25.11M 1.73B 25.22M 67.38M 883M 68.3M 66.83M 2.81B
Net Debt -188M -19.57M -16.81M -15.83M -14.44M -27M -1.86B -27.11M -72.45M -950M -73.44M -71.86M -3.03B -222M -23.16M -19.89M -18.73M -17.09M -31.95M -2.2B -32.09M -85.74M -1.12B -86.91M -85.04M -3.58B
Logo CellaVision AB
CellaVision AB is a Sweden-based company active in the medical technology sector. The Company develops and sells digital solutions for medical microscopy, as well as products enabling blood cell analysis and morphology diagnosis. CellaVision AB’s product portfolio consists of analyzers for automated medical microscopy analysis and software applications designed for remote access, competency testing and education. The analyzers include such brands as CellaVision DM96 and CellaVision DM1200, whereas the software applications are divided into CellaVision Body Fluid Application, CellaVision Remote Review Software and CellaVision Competency Software, among others. The Company operates four subsidiaries, based in Sweden, Canada, the United States and Japan. In June 2014, CellaVision AB acquired technology platform from Clear Lake Medical Foundation.
Employees
251
Date Price Change Volume
26-09-09 SEK 161.00 -0.74% 36,539
26-09-08 SEK 162.20 +0.12% 20,666
26-09-07 SEK 162.00 +1.00% 33,231
26-09-04 SEK 160.40 -1.35% 27,807
26-09-03 SEK 162.60 -0.12% 29,805
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
161.00SEK
Average target price
175.67SEK
Spread / Average Target
+9.11%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CEVI Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!